Fig. 1 · Structure
Documents & Downloads
AF-CX 921
Antiepileptic Drug
AF-CX 921 is a potent antiepileptic agent that targets neuronal excitability to modulate seizure activity. It exhibits significant anticonvulsant effects and is utilized in research focused on epilepsy models and mechanisms of seizure control. AF-CX 921 aids in the exploration of novel therapeutic pathways for seizure management and the development of new antiepileptic therapies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 77946-49-7 |
| Applications | Antiepileptic Drug |
| Formula | C15H11NOS |
| Molecular Weight | 253.32 |
| SMILES | O=C1C2=CC=CC=C2S/C1=C(N)\C3=CC=CC=C3 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.